Aktana Status
The company raised $21.07 million of Series C venture funding from undisclosed investors on September 26, 2018, putting the company's pre-money valuation at $93.62 million.
Developer of a decision support platform that synthesizes and prioritizes data to provide commercial teams relevant insights and suggested actions within their workflows. The company's platform harnesses machine learning algorithms, analyzes market data, channel activity and HCP preference in real-time, enabling pharmaceutical companies to increase revenue, capitalize on data investments, and drive channel productivity and results.
Year Founded
2008
Employees
120
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Venture Capital-Backed
Aktana News and Updates
Alan Kalton Jim Anderson and Pini Ben-Or, Author at MedCity News
MedCity News | January 18, 2021
2021's crystal ball: 6 AI predictions that will shape a new commercial model
MedCity News | January 18, 2021
AI Career Notes: January 2021 Edition
EnterpriseAI | January 6, 2021
Sonde Health adds new sales leads in U.S., India; ATA names Joe Kvedar next chair of board; and other digital health hires
Mobihealth News | January 4, 2021
Safeguard Scientifics Announces Appointment Of Eric C. Salzman As CEO
PRNewswire | December 21, 2020
Movers & Shakers, Dec. 18 | BioSpace
BioSpace | December 18, 2020
Aktana's Feed
Aktana's Verticals
Aktana Primary Industry Sector / Group / Code
Aktana's Trends
Aktana Metrics
Growth Rate
SimilarWeb Unique Visitors
Majestic Referring Domains
Twitter Followers
Headquarters
-
HQ Address Line 1207 Powell Street
-
HQ Address Line 28th Floor
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94102
-
HQ CountryUnited States
Aktana's Keywords
Add a review